Wegovy 0.5mg Flextouch Pre Filled Pen

Wegovy 0.5mg Flextouch Pre Filled Pen contains Semaglutide 0.5mg, a GLP-1 receptor agonist used for chronic weight management and to reduce the risk of major cardiovascular events in certain adults.

Benefits

This medicine aids in significant and sustained weight loss when combined with a reduced-calorie diet and increased physical activity. It helps regulate appetite, reduces hunger, and promotes feelings of fullness, contributing to a lower calorie intake. Additionally, Wegovy 0.5mg Flextouch Pre Filled Pen is indicated to reduce the risk of major adverse cardiovascular events in adults with established cardiovascular disease who are also obese or overweight. It may also offer benefits for liver health in adults with metabolic dysfunction-associated steatohepatitis (MASH).

Uses and Indications

• Long-term weight management in adults with obesity (BMI ≥30 kg/m²) or overweight (BMI ≥27 kg/m²) in the presence of at least one weight-related comorbidity.
• Reduction of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke) in adults with established cardiovascular disease and either obesity or overweight.
• Weight management in adolescents aged 12 years and older with obesity.
• Treatment of noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) with moderate to advanced liver fibrosis in adults.

The Wegovy 0.5mg Flextouch Pre Filled Pen contains:

• Semaglutide 0.5mg (active ingredient).
• Excipients: disodium phosphate dihydrate, propylene glycol, phenol, sodium hydroxide/hydrochloric acid (for pH adjustment), water for injection.

Dosage and Administration

1. The Wegovy 0.5mg Flextouch Pre Filled Pen is administered as a once-weekly subcutaneous injection.
2. Injections can be given at any time of day, with or without meals, on the same day each week.
3. Inject under the skin in the abdomen, thigh, or upper arm, rotating injection sites each week.
4. The starting dose is typically 0.25 mg once weekly, gradually increasing over 16 weeks to a maintenance dose as prescribed by a healthcare professional.
5. Always follow the specific dosing schedule and instructions provided by your doctor or pharmacist.

Storage and Disposal

• Store the Wegovy 0.5mg Flextouch Pre Filled Pen in a refrigerator (2°C to 8°C / 36°F to 46°F) in its original carton to protect from light.
• Do not freeze Wegovy, and do not use it if it has been frozen.
• Once in use, the pen can be stored for up to 6 weeks at a temperature below 30°C (86°F) or in a refrigerator (2°C to 8°C).
• Keep out of the sight and reach of children.
• Dispose of the used pen safely in an FDA-approved sharps container; do not discard in household trash.

Precautions and Safety

• Wegovy is a prescription-only medicine and should be used strictly under medical supervision.
• Inform your doctor about all medical conditions, especially if you have a history of thyroid C-cell tumors, pancreatitis, gallbladder problems, kidney problems, or diabetic retinopathy.
• Patients with type 2 diabetes taking insulin or sulfonylureas may have an increased risk of low blood sugar (hypoglycemia); dose adjustments of other diabetes medicines may be necessary.
• Do not share your Wegovy 0.5mg Flextouch Pre Filled Pen with others, even if the needle is changed, as this carries a risk of infection.
• Ensure the solution is clear and colourless before injection; do not use if cloudy or coloured.

Side Effects and Risks

• Common side effects include nausea, vomiting, diarrhea, constipation, stomach pain, headache, dizziness, and fatigue.
• Serious side effects can include pancreatitis, gallbladder problems, severe gastrointestinal issues, kidney problems (due to dehydration), increased heart rate, and serious allergic reactions.
• Report any severe or persistent stomach pain, signs of allergic reaction (rash, swelling, breathing difficulties), or vision changes to your doctor immediately.
• Wegovy has a boxed warning regarding the risk of thyroid C-cell tumors in rodents; the human relevance is unknown. Report any neck lumps, hoarseness, or difficulty swallowing to your doctor.

Disclaimer

Use this medicine only under the prescription and guidance of a qualified doctor or pharmacist.